產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-Calcyphosine 1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Calcyphosine 1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Calcyphosine 1
Cat. Number:
Anti-Calcyphosine 1抗體KL-12161R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CAPS1 is a 189 amino acid cytoplasmic protein that contains four EF-hand domains, which serve as calcium-binding sites, and was first identified in canine thyroid. Interestingly, CAPS1 is much less abundant in humans than in canines. Synthesis and phosphorylation of CAPS1 is upregulated by cAMP-agonists in thyrocytes. Anti-Calcyphosine 1抗體CAPS1 likely functions in the regulation of ionic transport and may be involved in cross-signaling between cAMP and Ca(+2)-phophatidylinositol cascades. In addition to thyriod, CAPS1 is expressed in brain, salivary glands and lung. Expression of CAPS1 is increased in endometrial cancer and prognosis seems to be dependent on the level of CAPS1 expression, indicating that CAPS1 may be an appropriate prognostic marker for patient survival.
Also known as:
Calcyphosin; Calcyphosine 1;Anti-Calcyphosine 1抗體 Calcyphosine; CAPS; CAPS1; CAYP1_HUMAN; Thyroid protein p24.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Dog, Pig, Cow, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Calcyphosine 1.
●
Predicted Molecular Weight: 21kDa.
Storage:
Shipped at 4℃, Store Anti-Calcyphosine 1抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-Calcyphosine 1抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-Calcyphosine 1抗體dilutions must be determined by the end user.
kl559Mu02 絲切蛋白1(CFL1)多克隆抗體 Polyclonal Antibody to Cofilin 1, Non Muscle (CFL1)
kl559Ra01 絲切蛋白1(CFL1)多克隆抗體 Polyclonal Antibody to Cofilin 1, Non Muscle (CFL1)
kl560Mu02 ****β(LTβ)多克隆抗體 Polyclonal Antibody to Lymphotoxin Beta (LTb)
kl560Ra01 ****β(LTβ)多克隆抗體 Polyclonal Antibody to Lymphotoxin Beta (LTb)
kl564Mu02 干擾素調(diào)節(jié)因子1(IRF1)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 1 (IRF1)
kl566Ra01 肝型脂肪酸結(jié)合蛋白(FABP1)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 1, Liver (FABP1)
kl570Mu01 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
kl570Mu02 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
kl571Mu02 胸腺激活調(diào)節(jié)趨化因子(TARC)多克隆抗體 Polyclonal Antibody to Thymus Activation Regulated Chemokine (TARC)
kl572Ra01 **細(xì)胞功能關(guān)聯(lián)抗原1α(LFA1α)多克隆抗體 Polyclonal Antibody to Lymphocyte Function Associated Antigen 1 Alpha (LFA1a)
kl573Hu01 粘膜關(guān)聯(lián)上皮趨化因子(MEC)多克隆抗體 Polyclonal Antibody to Mucosae Associated Epithelia Chemokine (MEC)
kl575Mu02 二級(jí)**組織趨化因子(SLC)多克隆抗體 Polyclonal Antibody to Secondary Lymphoid Tissue Chemokine (SLC)
kl578Mu02 IgG-Fc片段受體Ⅰ(FcγRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin G (FcgRI)
kl581Mu01 IgE-Fc受體Ⅰ(FcεRⅠ)多克隆抗體 Polyclonal Antibody to Receptor I For The Fc Region Of Immunoglobulin E (FceRI)
